MeiraGTx Holdings PLC (MGTX) - Net Assets

Latest as of December 2025: $-5.79 Million USD

Based on the latest financial reports, MeiraGTx Holdings PLC (MGTX) has net assets worth $-5.79 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($244.43 Million) and total liabilities ($250.22 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MeiraGTx Holdings PLC (MGTX) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets $-5.79 Million
% of Total Assets -2.37%
Annual Growth Rate N/A
5-Year Change -103.12%
10-Year Change N/A
Growth Volatility 70.94

MeiraGTx Holdings PLC - Net Assets Trend (2016–2025)

This chart illustrates how MeiraGTx Holdings PLC's net assets have evolved over time, based on quarterly financial data. Also explore how large is MeiraGTx Holdings PLC's balance sheet for the complete picture of this company's asset base.

Annual Net Assets for MeiraGTx Holdings PLC (2016–2025)

The table below shows the annual net assets of MeiraGTx Holdings PLC from 2016 to 2025. For live valuation and market cap data, see MGTX company net worth.

Year Net Assets Change
2025-12-31 $-5.79 Million -108.54%
2024-12-31 $67.83 Million -50.91%
2023-12-31 $138.18 Million +17.36%
2022-12-31 $117.74 Million -36.50%
2021-12-31 $185.40 Million -22.28%
2020-12-31 $238.56 Million +25.03%
2019-12-31 $190.80 Million +135.39%
2018-12-31 $81.06 Million +271.14%
2017-12-31 $-47.37 Million -176.36%
2016-12-31 $-17.14 Million --

Equity Component Analysis

This analysis shows how different components contribute to MeiraGTx Holdings PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 78184369200.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock $3.00K %
Other Comprehensive Income $2.41 Million %
Other Components $808.02 Million %
Total Equity $-5.79 Million 100.00%

MeiraGTx Holdings PLC Competitors by Market Cap

The table below lists competitors of MeiraGTx Holdings PLC ranked by their market capitalization.

Company Market Cap
Resurs Holding AB
ST:RESURS
$760.84 Million
Siri Prime Office Property Fd
BK:SIRI
$760.88 Million
Heilongjiang Publishing & Media Co Ltd
SHG:605577
$760.92 Million
Linewell Software Co Ltd
SHG:603636
$760.93 Million
CJ ENM CO. Ltd
KQ:035760
$760.56 Million
BOROSIL RENEWABLES LIMITED
NSE:BORORENEW
$760.32 Million
Central Reinsurance Corp
TW:2851
$760.28 Million
Sky Gold Limited
NSE:SKYGOLD
$760.24 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in MeiraGTx Holdings PLC's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 67,827,000 to -5,793,000, a change of -73,620,000 (-108.5%).
  • Net loss of 114,201,000 reduced equity.
  • New share issuances of 15,074,000 increased equity.
  • Other comprehensive income increased equity by 6,125,000.
  • Other factors increased equity by 19,382,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-114.20 Million -1971.36%
Share Issuances $15.07 Million +260.21%
Other Comprehensive Income $6.12 Million +105.73%
Other Changes $19.38 Million +334.58%
Total Change $- -108.54%

Book Value vs Market Value Analysis

This analysis compares MeiraGTx Holdings PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 $-0.89 $9.41 x
2017-12-31 $-5.53 $9.41 x
2018-12-31 $4.28 $9.41 x
2019-12-31 $5.75 $9.41 x
2020-12-31 $6.32 $9.41 x
2021-12-31 $4.20 $9.41 x
2022-12-31 $2.61 $9.41 x
2023-12-31 $2.45 $9.41 x
2024-12-31 $0.97 $9.41 x
2025-12-31 $-0.07 $9.41 x

Capital Efficiency Dashboard

This dashboard shows how efficiently MeiraGTx Holdings PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -140.31%
  • • Asset Turnover: 0.33x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-58.69%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 0.00% 0.00% 0.00x 0.00x $-17.77 Million
2017 0.00% 0.00% 0.00x 0.00x $-26.31 Million
2018 -102.23% 0.00% 0.00x 1.20x $-90.97 Million
2019 -28.69% -411.87% 0.04x 1.70x $-73.83 Million
2020 -24.31% -372.63% 0.04x 1.52x $-81.85 Million
2021 -42.91% -211.03% 0.12x 1.73x $-98.10 Million
2022 -110.09% -814.16% 0.05x 2.70x $-141.39 Million
2023 -60.81% -599.46% 0.04x 2.36x $-97.84 Million
2024 -217.89% -444.10% 0.12x 3.98x $-154.57 Million
2025 0.00% -140.31% 0.33x 0.00x $-113.62 Million

Industry Comparison

This section compares MeiraGTx Holdings PLC's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $44,828,400
  • Average return on equity (ROE) among peers: -124.18%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
MeiraGTx Holdings PLC (MGTX) $-5.79 Million 0.00% N/A $760.71 Million
Aardvark Therapeutics, Inc. Common Stock (AARD) $-54.64 Million 0.00% 0.00x $118.88 Million
Abcellera Biologics Inc (ABCL) $10.25 Million -21.57% 1.29x $1.07 Billion
Abeona Therapeutics Inc (ABEO) $3.60 Million -91.89% 0.28x $292.09 Million
Acumen Pharmaceuticals Inc (ABOS) $266.97 Million -19.62% 0.16x $171.87 Million
Abpro Holdings, Inc. (ABP) $3.07 Million -479.81% 1.57x $448.19K
Absci Corp (ABSI) $67.00 Million -21.42% 0.32x $345.85 Million
Arbutus Biopharma Corp (ABUS) $88.00 Million -44.09% 0.34x $840.56 Million
ABVC Biopharma Inc (ABVC) $80.00K -31.70% 0.38x $26.41 Million
Abivax SA American Depositary Shares (ABVX) $40.58 Million -434.26% 4.06x $9.33 Billion
ACADIA Pharmaceuticals Inc (ACAD) $23.36 Million -97.44% 0.37x $3.74 Billion

About MeiraGTx Holdings PLC

NASDAQ:MGTX USA Biotechnology
Market Cap
$766.41 Million
Market Cap Rank
#10413 Global
#2607 in USA
Share Price
$9.41
Change (1 day)
+2.06%
52-Week Range
$4.64 - $11.29
All Time High
$30.01
About

MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also develops AAV-AQP1 for radiation-induced grade 2/3 radiation-induced xe… Read more